1. Home
  2. GHRS vs ECVT Comparison

GHRS vs ECVT Comparison

Compare GHRS & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • ECVT
  • Stock Information
  • Founded
  • GHRS 2018
  • ECVT 1935
  • Country
  • GHRS Ireland
  • ECVT United States
  • Employees
  • GHRS N/A
  • ECVT 920
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • ECVT Major Chemicals
  • Sector
  • GHRS Health Care
  • ECVT Industrials
  • Exchange
  • GHRS Nasdaq
  • ECVT Nasdaq
  • Market Cap
  • GHRS 960.2M
  • ECVT 1.0B
  • IPO Year
  • GHRS 2021
  • ECVT 2017
  • Fundamental
  • Price
  • GHRS $14.38
  • ECVT $8.54
  • Analyst Decision
  • GHRS Strong Buy
  • ECVT Strong Buy
  • Analyst Count
  • GHRS 8
  • ECVT 4
  • Target Price
  • GHRS $30.63
  • ECVT $10.00
  • AVG Volume (30 Days)
  • GHRS 353.0K
  • ECVT 1.5M
  • Earning Date
  • GHRS 09-02-2025
  • ECVT 08-07-2025
  • Dividend Yield
  • GHRS N/A
  • ECVT N/A
  • EPS Growth
  • GHRS N/A
  • ECVT N/A
  • EPS
  • GHRS N/A
  • ECVT N/A
  • Revenue
  • GHRS N/A
  • ECVT $706,153,000.00
  • Revenue This Year
  • GHRS N/A
  • ECVT $15.53
  • Revenue Next Year
  • GHRS N/A
  • ECVT $5.11
  • P/E Ratio
  • GHRS N/A
  • ECVT N/A
  • Revenue Growth
  • GHRS N/A
  • ECVT 2.23
  • 52 Week Low
  • GHRS $6.00
  • ECVT $5.24
  • 52 Week High
  • GHRS $20.50
  • ECVT $9.63
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 46.75
  • ECVT 51.72
  • Support Level
  • GHRS $12.81
  • ECVT $8.64
  • Resistance Level
  • GHRS $15.28
  • ECVT $9.07
  • Average True Range (ATR)
  • GHRS 1.49
  • ECVT 0.23
  • MACD
  • GHRS -0.41
  • ECVT -0.05
  • Stochastic Oscillator
  • GHRS 20.60
  • ECVT 15.60

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About ECVT Ecovyst Inc.

Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.

Share on Social Networks: